2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells

Genes and Immunity

Volumn 16, Issue 5, 2015, Pages 301-310

  Dunphy, S E ^a   Guinan, K J ^b   Chorcora, C Ní ^a   Jayaraman, J ^c   Traherne, J A ^c,d   Trowsdale, J ^d   Pende, D ^e   Middleton, D ^f   Gardiner, C M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b BIOATLANTIS LTD   (Ireland)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF GENOA   (Italy)

^f ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3;

ALLELE; ALLOTYPE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; GENETIC POLYMORPHISM; GENETICS; METABOLISM;

ALLELES; HUMANS; KILLER CELLS, NATURAL; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, KIR;

EID: 84937816086     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2015.15     Document Type: Article

References (32)

1. O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology 2006; 117: 1-10.
2. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1: 41-49.
3. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217-251.
4. Robinson J, Waller MJ, Stoehr P, Marsh SG. IPD-the immuno polymorphism database. Nucleic Acids Res 2005; 33 Database issue D523-D526.
5. Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001; 166: 2992-3001.
6. Gagne K, Willem C, Legrand N, Djaoud Z, David G, Rettman P et al. Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population. Eur J Immunol 2013; 43: 1085-1098.
7. Thomas R, Yamada E, Alter G, Martin MP, Bashirova AA, Norman PJ et al. Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J Immunol 2008; 180: 6743-6750.
8. Goodridge JP, Lathbury LJ, Steiner NK, Shulse CN, Pullikotil P, Seidah NG et al. Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells. Eur J Immunol 2007; 37: 199-211.
9. Goodridge JP, Witt CS, Christiansen FT, Warren HS. KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 2003; 171: 1768-1774.
10. Middleton D, Gonzalez A, Gilmore PM. Studies on the expression of the deleted KIR2DS4∗003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations. Hum Immunol 2007; 68: 128-134.
11. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006; 203: 633-645.
12. Schonberg K, Sribar M, Enczmann J, Fischer JC, Uhrberg M. Analyses of HLA-Cspecific KIR repertoires in donors with group. A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 2011; 117: 98-107.
13. Beziat V, Traherne JA, Liu LL, Jayaraman J, Enqvist M, Larsson S et al. Influence of KIR gene copy number on natural killer cell education. Blood 2013; 121: 4703-4707.
14. Wright PW, Li H, Huehn A, O'Connor GM, Cooley S, Miller JS et al. Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression. Genes Immun 2014; 15: 440-448.
15. Li H, Pascal V, Martin MP, Carrington M, Anderson SK. Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 2008; 4: e1000254.
16. Charoudeh HN, Terszowski G, Czaja K, Gonzalez A, Schmitter K, Stern M. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Eur J Immunol 2013; 43: 480-487.
17. Guinan KJ, Cunningham RT, Meenagh A, Gonzalez A, Dring MM, McGuinness BW et al. Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes. Genes Immun 2010; 11: 467-478.
18. Babor F, Manser AR, Fischer JC, Scherenschlich N, Enczmann J, Chazara O et al. KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse. Blood 2014; 124: 2248-2251.
19. Guinan KJ, Cunningham RT, Meenagh A, Dring MM, Middleton D, Gardiner CM. Receptor systems controlling natural killer cell function are genetically stratified in Europe. Genes Immun 2010; 11: 67-78.
20. Uhrberg M, Parham P, Wernet PDefinition of gene content for nine common group. B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002; 54: 221-229.
21. Beziat V, Traherne J, Malmberg JA, Ivarsson MA, Bjorkstrom NK, Retiere C et al. Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation. Eur J Immunol 2014; 44: 2192-2196.
22. Pando MJ, Gardiner CM, Gleimer M, McQueen KL, Parham P. The protein made from a common allele of KIR3DL1 (3DL1∗004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 2003; 171: 6640-6649.
23. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23: 225-274.
24. Borrego F, Masilamani M, Marusina AI, Tang X, Coligan JE. The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. Immunol Res 2006; 35: 263-278.
25. Pegram HJ, Andrews DM, Smyth MJ, Darcy PK, Kershaw MH. Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol 2011; 89: 216-224.
26. Middleton D, Curran M, Maxwell L. Natural killer cells and their receptors. Transpl Immunol 2002; 10: 147-164.
27. Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004; 64: 215-225.
28. Bari R, Bell T, Leung WH, Vong QP, Chan WK, Das Gupta N et al. Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood 2009; 114: 5182-5190.
29. Andersson S, Fauriat C, Malmberg JA, Ljunggren HG, Malmberg KJ. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 2009; 114: 95-104.
30. Beziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Bjorklund AT et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013; 121: 2678-2688.
31. Davidson CL, Li NL, Burshtyn DN. LILRB1 polymorphism and surface phenotypes of natural killer cells. Hum Immunol 2010; 71: 942-949.
32. Jiang W, Johnson C, Jayaraman J, Simecek N, Noble J, Moffatt MF et al. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res 2012; 22: 1845-1854.